Benda Pharmaceutical, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.23
from SB-2/A 1 page The Science and Technology Cooperation Agreement Between College of Chemistry and Life Science of China Three Gorges University and Yidu Benda
12/34/56
EX-10.22
from SB-2/A 3 pages Co-Operative Agreement on Yanlong Anticancer Ordal Liquid
12/34/56
EX-10.21
from SB-2/A 3 pages Interview by Eric Yu for WALLST.NET Dated July 26, 2007 Small Cap Voice (Audio Interview) 1. for Those Not Familiar With Your Company, Please Describe Your Company and Its Business Model
12/34/56
EX-10.2
from 8-K 4 pages January 2, 2008 Mr. Wan Yi (Charles) Qing Room 16, Floor 25, Sunny New World Tower No. 231 Xin Hua Road Jianghan District Wuhan, Hu Bei Prc 430015 1. the Company Has Engaged Eastgate and Eastgate Has Agreed to Provide the Advisory Services on the Terms and Conditions Set Forth in This Agreement. 2. Eastgate Shall Provide Advisory Services to the Company Regarding Such Matters as Eastgate and the Company Shall Agree. 3. Specifically, Eastgate Will, at the Request of the Company or With the Agreement of the Company
12/34/56
EX-10.1
from 8-K 8 pages January 2, 2008 Benda Pharmaceutical, Inc. Sunny New World Tower, 25th Floor, Room 13 231 Xin Hua Road, Jianghan District Wuhan, Hubei Province, Prc 430015 Attention: Wan Yi Qing Title: Chairman and Chief Executive Officer
12/34/56
EX-10.12
from 8-K/A 7 pages Equity Transfer Agreement
12/34/56
EX-10.11
from 8-K/A 4 pages Technical Consultancy Agreement
12/34/56
EX-10.10
from 8-K/A 7 pages Equity Transfer Agreement Translation
12/34/56
EX-10.9
from 8-K/A 4 pages Technical Consultancy Agreement This Technical Consultancy Agreement (The “Agreement”), Entered Into as of June 11, 2007, Between Benda Pharmaceutical, Inc. (“Benda”), a Corporation Organized Under the Laws of Delaware of the United States, and Huimin Zhang (The “Consultant”)
12/34/56
EX-10.8
from 8-K 9 pages Modification and Amendment Agreement
12/34/56
EX-10.7
from 8-K 4 pages Financial Consultancy Agreement
12/34/56
EX-10.6
from 8-K 7 pages Equity Transfer Agreement Translation
12/34/56
EX-10.5
from 8-K 7 pages Equity Transfer Agreement Translation
12/34/56
EX-10.4
from 8-K 27 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 19 pages Benda Pharmaceutical, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 12 pages Benda Pharmaceutical, Inc. Convertible Promissory Note
12/34/56
EX-10.1
from 8-K 38 pages Investment Agreement
12/34/56
EX-10.11
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.10
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.9
from 8-K 11 pages Employment Agreement
12/34/56